Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Felbinac Trometamol Injection for Post-Surgical Pain
NCT03872830Phase 2Completed
- Sponsor
- Yiling Pharmaceutical
- Start
- Mar 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of felbinac in postoperative pain, sponsored by Yiling Pharmaceutical. Started Mar 2019; status: completed.
02
Drugs
felbinac
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03872830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03872830.